INIS
patients
100%
liver
88%
bile
84%
salts
78%
growth factors
64%
fibroblasts
64%
levels
43%
failures
43%
diseases
30%
therapy
28%
concentration
27%
amino acids
27%
rats
25%
humans
25%
spectra
25%
cholic acid
25%
regeneration
25%
feeding
22%
synthesis
21%
bile acids
21%
proteins
17%
injuries
17%
homeostasis
15%
citrulline
15%
plasma
14%
adults
14%
muscles
14%
risks
13%
urea
12%
creatinine
12%
Keyphrases
Bile Salts
86%
Fibroblast Growth Factor 19 (FGF19)
84%
Intestinal Failure
29%
Critical Illness
28%
Rat Model
25%
Zellweger Spectrum Disorder
25%
Cholic Acid
25%
Liver Regeneration
25%
Bile
23%
Intermittent Feeding
21%
Continuous Feeding
21%
Adult Patients
17%
Amino Acid Content
17%
Critically Ill Patients
17%
Liver Injury
15%
Salt Homeostasis
14%
Citrulline
14%
Partial Liver Resection
14%
Muscle Wasting
14%
Circulating Concentration
12%
Poor Survival
12%
Human Liver
12%
Chyme Reinfusion
12%
Intestinal Failure-associated Liver Disease (IFALD)
12%
Gastrointestinal Tract
12%
Gallbladder Dyskinesia
12%
Failure Risk
12%
Amino Acids
12%
Agonism
12%
Biliary Drainage
12%
Medicine and Dentistry
Fibroblast Growth Factor 19
84%
Bile Salt
74%
Intestinal Failure
38%
Bile
25%
Liver Regeneration
25%
Liver Injury
17%
Critical Illness
15%
Cholestasis
15%
Citrulline
14%
Partial Hepatectomy
14%
Liver Disease
14%
Viscera
12%
Dyskinesia
12%
Clinical Trial
12%
Biliary Tract Drainage
12%
Muscle Atrophy
12%
Cholic Acid
12%
Chenodeoxycholic Acid
12%
Spectrum Disorder
12%
Primary Sclerosing Cholangitis
12%
Cholangiocarcinoma
12%
Parenteral Nutrition-Associated Liver Disease
12%
Enteric Feeding
8%
Intensive Care Unit
5%